Alaunos Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Alaunos Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Alaunos Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$1.13M, a 87.1% increase year-over-year.
  • Alaunos Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$19.1M, a 48.1% increase year-over-year.
  • Alaunos Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$35.1M, a 6.87% increase from 2022.
  • Alaunos Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$37.7M, a 52.1% increase from 2021.
  • Alaunos Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$78.8M, a 1.53% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$35.1M +$2.59M +6.87% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$37.7M +$41M +52.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$78.8M +$1.23M +1.53% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 -$80M +$37.8M +32.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 -$118M -$64.7M -122% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 -$53.1M +$1.21M +2.22% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$54.3M +$111M +67.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$165M -$45.2M -37.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-05
2015 -$120M -$88.3M -278% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$31.8M +$25.3M +44.3% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-16
2013 -$57.1M +$39M +40.6% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-24
2012 -$96.1M -$32.4M -50.7% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-26
2011 -$63.8M -$31.1M -95.2% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-03
2010 -$32.7M Jan 1, 2010 Dec 31, 2010 10-K 2014-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.